Canada Life’s Genomic Health, Inc. GHDX Stock Holding History

Canada Life’s Portfolio GHDX Stock Details GHDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-3,173	Closed	-$184K	–	2702
2019 Q2	$184K	Buy	3,173 +440	+16%	+$26.1K	﹤0.01%	2049
2019 Q1	$191K	Hold	2,733	–	–	﹤0.01%	1888
2018 Q4	$170K	Hold	2,733	–	–	﹤0.01%	1978
2018 Q3	$192K	Hold	2,733	–	–	﹤0.01%	1991
2018 Q2	$138K	Sell	2,733 -1,049	-28%	-$41.6K	﹤0.01%	2090
2018 Q1	$119K	Hold	3,782	–	–	﹤0.01%	2116
2017 Q4	$129K	Buy	3,782 +2,855	+308%	+$91K	﹤0.01%	2102
2017 Q3	$29K	Hold	927	–	–	﹤0.01%	2447
2017 Q2	$30K	Hold	927	–	–	﹤0.01%	2444
2017 Q1	$29K	Hold	927	–	–	﹤0.01%	2419
2016 Q4	$27K	Hold	927	–	–	﹤0.01%	2451
2016 Q3	$27K	Hold	927	–	–	﹤0.01%	2445
2016 Q2	$24K	Hold	927	–	–	﹤0.01%	2447
2016 Q1	$23K	Hold	927	–	–	﹤0.01%	2331
2015 Q4	$33K	Hold	927	–	–	﹤0.01%	2278
2015 Q3	$20K	Hold	927	–	–	﹤0.01%	2317
2015 Q2	$26K	Hold	927	–	–	﹤0.01%	2407
2015 Q1	$28K	Hold	927	–	–	﹤0.01%	2272
2014 Q4	$30K	Sell	927 -246	-21%	-$8.01K	﹤0.01%	2257
2014 Q3	$33K	Hold	1,173	–	–	﹤0.01%	2193
2014 Q2	$32K	Hold	1,173	–	–	﹤0.01%	2130
2014 Q1	$31K	Hold	1,173	–	–	﹤0.01%	2026
2013 Q4	$36K	Buy	+1,173	New	+$37.2K	﹤0.01%	1972

Other funds holding GHDX

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

Canada Life's GHDX Position: Q3 2019 in Review

Canada Life sold out of Genomic Health, Inc. (GHDX) in Q3 2019, closing a stake of 3,173 shares — an estimated $184K sold.

Canada Life first reported a position in GHDX in Q4 2013 and held it in 23 quarters. The position peaked at $192K in Q3 2018. 221 funds tracked by Wall St. Rank hold GHDX as of Q3 2019.

Canada Life reported no remaining Genomic Health, Inc. position as of Q3 2019 after selling out during the quarter.
Canada Life sold 3,173 Genomic Health, Inc. shares in Q3 2019, an estimated $184K.
Canada Life first reported a position in Genomic Health, Inc. in Q4 2013 and held it in 23 quarters.
Canada Life's Genomic Health, Inc. position peaked at $192K in Q3 2018.
221 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q3 2019.

Based on Canada Life's 13F filing for Q3 2019, filed 25 Oct 2019.